USA: PharmaKinetics Q4 shr $0.03 vs loss $0.03.PharmaKinetics Q4 shr $0.03 vs loss $0.03.PharmaKinetics Laboratories, Inc		     (000's) Except share and per share data			   Three months ended	 Years ended		  June 30,     June  30,	 June 30,  June 30,			  1996	  1995	   1995	 1995 Contract revenue  $3,206	$2,221	$10,962     $9,894Earnings (loss) from   operations	   440	( 399)	    982	  462Other expenseInterest expense, net			   (43)	  (54)	  (182)	(215)Loss on sale of investments			     --	    --	     --	(101)Write-down of investments			     --	    --	     --	 (47)Loss on sale of equipment			   (15)	    --	   (17)	   --Provision for (benefit of)   income taxes	   4	  (29)		4	 (29) Net earnings (loss)  378	( 424)	    779	  128Net earnings (loss) per   share		 0.03     ( 0.03)	   0.06	 0.01Weighted average sharesoutstanding		  12,360,018  12,395,891   12,319,646  12,598,102-- New York Newsdesk 212 859-1610